[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-348972-105":59,"doc-detail-348972-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pir-37524-overexpression-in-colorectal-cancer-a-potential-diagnostic-bio-marker-and-therapeutic-target","piR-37524 Overexpression in Colorectal Cancer - A Potential Diagnostic Bio-Marker and Therapeutic Target","","Objectives: Piwi-associated RNAs are small non-coding RNAs implicated in cancer, yet few have been characterized in colorectal cancer (CRC). This study identifies a CRC-related piRNA and examines clinical relevance, biological function, and biomarker potential. Methods: piR-37524 is quantified by qRT-PCR across CRC tissues, matched adjacent non-tumor tissues, adenomas, liver metastases, and serum. Functional assays assess proliferation, colony formation, and migration after piR-37524 inhibition. RNA sequencing and Western blotting analyze EMT and NF-κB signaling components. Results: piR-37524 is significantly overexpressed in CRC and correlates with tumor aggressiveness. Elevated serum levels support diagnostic performance. Mechanism links TNFAIP3-associated NF-κB signaling to EMT regulation. Conclusions: piR-37524 acts as an oncogenic piRNA and a potential pan-stage diagnostic biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pir-37524-overexpression-in-colorectal-cancer-a-potential-diagnostic-bio-marker-and-therapeutic-target/348972/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pir-37524-overexpression-in-colorectal-cancer-a-potential-diagnostic-bio-marker-and-therapeutic-target/348972.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary objective of the study on piR-37524 in colorectal cancer?","Question",{"text":112,"@type":113},"To identify a CRC-related piRNA (piR-37524) and determine its clinical relevance, biological role, and biomarker potential in colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was piR-37524 expression measured across patient samples?",{"text":117,"@type":113},"piR-37524 was quantified using qRT-PCR in colorectal cancer tissues, matched adjacent non-tumor tissues, colorectal adenomas, liver metastases, and serum samples from patients and healthy controls.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did piR-37524 inhibition have on CRC cells?",{"text":121,"@type":113},"Inhibition suppressed CRC cell proliferation and migration, with molecular changes consistent with epithelial–mesenchymal transition (EMT) regulation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},348972,1790230665,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Tech Science Press  \nDoi:10.32604/or.2026.074981  \nARTICLE  \npiR-37524 Overexpression in Colorectal Cancer: A Potential Diagnostic Bio-Marker and Therapeutic Target  \nJiaxi Li\\#, Deepak Iyer\\#, Siming Sui, Zheng Huang, Ryan Wai-Yan Sin, Abraham Tak-Ka Man, Wai-Lun Law, Chi-Chung Foo* and Lui Ng*  \nDepartment of Surgery, School of Clinical Medicine, LiKa Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, 999077, China  \n*Corresponding Authors: Chi-Chung Foo. Email: ccfoo@hku.hk; Lui Ng. Email: luing@hku.hk  \n\\# Jiaxi Li and Deepak Iye contributed equally to this study and share first authorship Received: 22 October 2025; Accepted: 31 December 2025; Published: 23 March 2026  \nABSTRACT: Objectives: Piwi-associated RNAs are small non-coding RNAs implicated in cancer, yet few have been characterized in colorectal cancer (CRC) . This study aimed to identify a CRC-related piRNA and investigate its clinical relevance, biological function, and biomarker potential. Methods: Candidates were identified by reanalysis of small-RNA sequencing. piR-37524 was quantified by quantitative real-time polymerase chain reaction (qRT-PCR) in colorectal cancer tissues, matched adjacent non-tumor tissues, colorectal adenomas, liver metastases, and serum samples from patients and healthy controls. Clinicopathological correlations and diagnostic performance were evaluated. Functional assays included 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) proliferation, colony formation, and wound-healing migration in HCT116 and HT29 cells after piR-37524 inhibition. RNA sequencing and Western blotting examined epithelial–mesenchymal transition (EMT) markers and nuclear factor-kappa B (NF-κB) components. Results: piR-37524 was significantly overexpressed in CRC compared with adjacent non-tumor tissues and was associated with larger tumor size, poorer differentiation, and distant metastasis. Elevated expression was also observed in colorectal adenomas and liver metastases. Serum piR-37524 levels were increased in patients with adenomas and CRC compared with healthy controls, indicating diagnostic potential. Functional assays demonstrated that piR-37524 inhibition suppressed CRC cell proliferation and migration, accompanied by changes consistent with epithelial–mesenchymal transition regulation. Mechanistic analyses implicated tumor necrosis factor alpha-induced protein 3 (TNFAIP3)-associated NF-κB signaling. Conclusions: piR-37524 is an oncogenic piRNA in CRC that promotes progression via the TNFAIP3/NF-κB/EMT axis, serving as a potential pan-stage diagnostic biomarker and therapeutic target.  \nKEYWORDS: Colorectal cancer; piRNAs; tumor biomarker  \n1 Introduction  \nColorectal cancer (CRC) ranks as a major global health concern, accounting for 9.6% of incident malignancies and 9.3% of cancer-related mortalities worldwide [1]. Despite decades of research elucidating its pathogenesis and molecular mechanisms, the rising global burden of CRC underscores persistent gapsin our understanding of disease progression. This necessitates the identification of novel biomarkers and therapeutic targets to improve clinical management strategies.  \nIn recent years, non-coding RNAs (ncRNAs) have been increasingly acknowledged as crucial modulators oftumor development. Among these, microRNAs (miRNAs) have been extensively shown to modulate  \nCopyright © 2026 The Authors. Published by Tech Science Press.  \nThis work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \ncancer-related pathways [2,3], while long non-coding RNAs (lncRNAs) have emerged as important drivers in tumor initiation and progression [4–6] . Recently, Piwi-interacting RNAs (piRNAs)—a class of 26–31 nucleotide small ncRNAs initially characterized in germline cells for their roles in transposon silencing, genome stability, and stem ","cbCaihoTCGcBqbJP","https://ap.wps.com/l/cbCaihoTCGcBqbJP","pdf",25516551,"English","# Abstract\n# Key Findings\n# 1 Introduction\n## Colorectal cancer burden\n## Non-coding RNAs and piRNAs in cancer\n## Study rationale for piR-37524","[{\"question\":\"What was the primary objective of the study on piR-37524 in colorectal cancer?\",\"answer\":\"To identify a CRC-related piRNA (piR-37524) and determine its clinical relevance, biological role, and biomarker potential in colorectal cancer.\"},{\"question\":\"How was piR-37524 expression measured across patient samples?\",\"answer\":\"piR-37524 was quantified using qRT-PCR in colorectal cancer tissues, matched adjacent non-tumor tissues, colorectal adenomas, liver metastases, and serum samples from patients and healthy controls.\"},{\"question\":\"What effects did piR-37524 inhibition have on CRC cells?\",\"answer\":\"Inhibition suppressed CRC cell proliferation and migration, with molecular changes consistent with epithelial–mesenchymal transition (EMT) regulation.\"}]","piR-37524 Overexpression in Colorectal Cancer - A Potential Diagnostic Bio-Marker and Therapeutic Target | PDF",1790080960,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11062352b11845510679a324854e8f84.webp",983,1271,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8ec644a41faa14f9c775dd8f0a267bb.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54a35967af9925772bffbce1e30f37a4.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efd10304557989461110f3689e415e9f.webp",980,1267]